Health ❯Pharmaceuticals

Diabetes

Medications Ozempic Type 2 Diabetes Obesity GLP-1 Agonists Drug Approvals GLP-1 Treatments GLP-1 Drugs

Biocon Secures CDSCO Approval for Generic Liraglutide

The biotech firm plans to roll out the Victoza equivalent rapidly through local commercialization partners to address India’s rising diabetes burden.

Study Investigates Vision Loss in Patients Using Popular Diabetes and Weight Loss Drugs

Eli Lilly Announces $3 Billion Wisconsin Manufacturing Expansion

Celebrities and Controversy: The Ozempic Weight Loss Debate

Model Lottie Moss Hospitalized After Misusing Ozempic for Weight Loss